Matthew Mefford to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Matthew Mefford has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.500
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.175
-
The association of hypertension, hypertension duration, and control with incident heart failure in black and white adults. J Clin Hypertens (Greenwich). 2020 05; 22(5):857-866.
Score: 0.167
-
Antihypertensive Medication Nonpersistence and Low Adherence for Adults <65 Years Initiating Treatment in 2007-2014. Hypertension. 2019 07; 74(1):35-46.
Score: 0.157